Loading company…
Resolvyx Pharmaceuticals develops therapies for inflammatory diseases.
Founded in 2005 and based in Cambridge, Resolvyx Pharmaceuticals developed therapies targeting inflammatory diseases. The company raised USD 4.00 mn in a Series B round that included Atlas Venture and Biogen Idec New Ventures. Celtic Therapeutics acquired Resolvyx in January 2011.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in